Despite the current situation regarding the Coronavirus, we will continue to ship your order. We stick to all the guidelines.
Our customer service is closed on Easter Monday (05-04-2021), King's Day (27-04-2021), Ascension Day (13-05-2021) and Whit Monday (24-05-2021).

Cart:

0 item(s) - €0.00
You have no items in your shopping cart.

Milbemax tasty chewable tablets | dog

Double click on above image to view full picture

Zoom Out
Zoom In

Milbemax tasty chewable tablets | dog


Quick Overview

The Milbemax tasty chewable tablet is a worming product for dogs. The product can be used for the treatment of mixed infections with adult tapeworms and roundworms. The product can also be used in the prevention of heartworm disease, if simultaneous treatment against tapeworms is required. The chewable tablet should be taken orally with or after some food.

The chewable tablet looks like a biscuit and has a nice chicken flavour. As a result almost all dogs eat the tablet just from the hand. The Milbemax chewable tablet makes worming a treat!

The Milbemax tasty chewable tablet for small dogs and puppies is suitable for small dogs and puppies weighing at least 1 kg. For a dog weighing between 1-5 kg is 1 chewable tablet recommended. The chewable tablet should not be administered to dogs weighing less than 1 kg.

The Milbemax tasty chewable tablet for dogs is suitable for dogs weighing at least 5 kg. The chewable tablet should not be administered to dogs weighing less than 5 kg. The dosage is determined on the basis of the body weight of the dog.

Dosage

Body weight of the dog Optimal dosage
Small dog and puppy 1-5 kg 1 chewable tablet - dog S
Dog 5-25 kg 1 chewable tablet - dog M
Dog 25-50 kg 2 chewable tablets - dog M
Dog 50-75 kg 3 chewable tablets - dog M
Product name Price Qty
Milbemax tasty chewable tablet | dog S | 1x4 tabl. | Expiration date 30-06-2022
€9.11
Milbemax tasty chewable tablet | dog M | 1x4 tabl.
€17.85
Milbemax tasty chewable tablet | dog S | 12x4 tabl. | Expiration date 31-03-2022
€101.37
Milbemax tasty chewable tablet | dog M | 12x4 tabl. Expiration date 31-08-2022
€272.50

Out of stock

OR

Details

Leaflet Milbemax chewable tablets for small dogs and puppies/Milbemax chewable tablets for dogs

USES
It is indicated in the dog for the treatment of mixed infections  by adult cestodes and nematodes of the following species:

  • Cestodes: Dipylidium caninum, Taenia spp., Echinococcus spp., Mesocestoides spp
  • Nematodes: Anclystoma caninum, Toxocara canis, Toxascaris leonina, Trichuris vulpis.

The product can also be used in the prevention of heartworm disease (Dirofilaria immitis), if concomitant treatment against cestodes is indicated.

CONTRA-INDICATIONS
Do not use “Milbemax chewable tablets for small dogs and puppies “in dogs weighing less than 1 kg.
Do not use “Milbemax chewable tablets for dogs”in dogs weighing less than 5 kg.
Do not use in case of hypersensitivity to the active substances or to any of the excipients.

Pregnancy and lactation
Milbemax can be used in pregnant and lactating bitches and in breeding animals.

DOSAGE AND ADMINISTRATION
The product should be administered with or after some food.

Depending on the bodyweight of the dog, the practical dosing is as follows:

Dosage

Body weight of the dog Optimal dosage
Small dog and puppy 1-5 kg 1 chewable tablet - dog S
Dog 5-25 kg 1 chewable tablet - dog M
Dog 25-50 kg 2 chewable tablets - dog M
Dog 50-75 kg 3 chewable tablets - dog M

 

In cases where heartworm disease prevention is used and at the same time treatment against tapeworm is required, the product can replace the monovalent product for the prevention of heartworm disease.

PRECAUTIONS FOR USE
Treatment of dogs with a high number of circulating microfilariae can sometimes lead to the appearance of hypersensitivity reactions, such as pale mucous membranes, vomiting, trembling, laboured breathing or excessive salivation. These reactions are associated with the release of proteins from dead or dying microfilariae and are not a direct toxic effect of the product. The use in dogs suffering from microfilaremia is thus not recommended.

In heartworm risk-areas, or in cases where it is known that a dog has been travelling to and from heartworm risk regions, before using MILBEMAX, a veterinary consultation is advised to exclude the presence of any concurrent infestation of Dirofilaria immitis. In the case of a positive diagnosis, adulticidal therapy is indicated before administering the product.
Echinococcosis represents a hazard for humans. In case of Echinococcosis, specific guidelines on the treatment and follow up and on the safeguard of persons have to be followed. Experts or institutes of parasitology should be consulted.
No studies have been performed with severely debilitated dogs or individuals with seriously compromised kidney or liver function. The product is not recommended for such animals or only according to a benefit/risk assessment by the responsible veterinarian.
In dogs less than 4 weeks old, tapeworm infection is unusual. Treatment of animals less than 4 weeks old with a combination product may therefore not be necessary.
Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.
In very rare occasions, systemic signs (such as lethargy), neurological signs (such as muscle tremors and ataxia) and/or gastrointestinal signs (such as emesis, drooling, diarrhoea and anorexia) have been observed in dogs after administration of Milbemax.
The adverse reactions observed following an overdose are the same as those observed at the recommended dose but more pronounced.
Wash hands after use.
In the event of accidental ingestion of the tablets, particularly by a child, seek medical advice immediately and show the package leaflet or the label to the doctor.

Storage precaution
Do not store above 25°C.
Keep out of the reach and sight of children.



Read more

Video

Additional Information

Animal (owner) Dog
Prescription required Netherlands No
Prescription required Germany Yes
Prescription required France No
Prescription required Spain Yes
Further information